Publicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (15)

2023

  1. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

2022

  1. Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study

    European Urology Focus, Vol. 8, Núm. 6, pp. 1673-1682

2021

  1. The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer – a multicentre observational study

    BJU International, Vol. 128, Núm. 4, pp. 440-450

2018

  1. A survey of perceptions, attitudes, knowledge and practices of medical oncologists about cancer pain management in Spain

    Clinical and Translational Oncology, Vol. 20, Núm. 8, pp. 1061-1071

2017

  1. Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: A multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)

    Annals of Oncology, Vol. 28, Núm. 12, pp. 2994-2999

2016

  1. A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia

    British Journal of Cancer, Vol. 114, Núm. 11, pp. 1191-1198

2014

  1. Análisis de impacto presupuestario del uso de fentanilo intranasal en pectina para el tratamiento del dolor irruptivo oncológico

    Pharmacoeconomics - Spanish Research Articles, Vol. 11, Núm. 2, pp. 51-60

  2. Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers

    Breast Cancer Research and Treatment, Vol. 148, Núm. 2, pp. 415-421

2013

  1. Optimal management of breakthrough cancer pain (BCP)

    Clinical and Translational Oncology, Vol. 15, Núm. 7, pp. 526-534

  2. Relationship between the pharmacokinetic properties and efficacy of fentanyl pectin nasal spray in breakthrough cancer pain

    Atencion Farmaceutica, Vol. 15, Núm. 1, pp. 40-45

2012

  1. Breakthrough cancer pain - Still a challenge

    Journal of Pain Research, Vol. 5, pp. 559-566

  2. Soft tissue myoepithelial carcinoma without EWSR1 gene rearrangement and poor outcome. A case report

    Revista Espanola de Patologia, Vol. 45, Núm. 1, pp. 58-63

2010

  1. Consensus document on the use of biosimilar granulocyte-colony stimulating factor for the correction of neutropenia associated in cancer patients

    Farmacia Hospitalaria, Vol. 34, Núm. SUPPL. 1, pp. 45-50

2009

  1. Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patients

    Clinical and Translational Oncology, Vol. 11, Núm. 11, pp. 727-736

2002

  1. Estudio de la astenia tumoral: Constituci-acon del grupo ASTHENOS

    Revista Clinica Espanola, Vol. 202, Núm. 10, pp. 525-528